Breast Cancer Survivorship app analytics for December 24
Breast Cancer Survivorship
- HKU TELI
- Apple App Store
- Free
- Health & Fitness
About Us
“Thrive HKU” is an initiative mobile application of The Department of Clinical Oncology, LKS Faculty of Medicine of the University of Hong Kong. “Thrive HKU” aims to provides better support for breast cancer survivors both physically and psychologically.
“Thrive HKU” equips breast cancer survivors with educational materials on breast cancer management and psychological support. Registered users will be given a Pink Fitbit which can encourage them to have more exercises and have a healthy lifestyle.
We wish breast cancer survivors who use the thrive app and Pink Fitbit every day can have a bright and healthy future!
Disclaimer
The information contained in this App is for general educational purpose and reference only. Such information is not medical advice, diagnosis or treatment on any individual case or patient and should not be treated as a substitute for professional medical advice, diagnosis or treatment. You should consult your attending doctor or health professional for any medical condition that you may have, rather than relying on the information provided in this App.
Store Rank
The Store Rank is based on multiple parameters set by Google and Apple.
All Categories in
Germany--
Health & Fitness in
Germany--
Create an account to see avg.monthly downloadsContact us
Breast Cancer Survivorship Ranking Stats Over Time
Similarweb's Usage Rank & Apple App Store Rank for Breast Cancer Survivorship
Rank
No Data Available
Breast Cancer Survivorship Ranking by Country
Counties in which Breast Cancer Survivorship has the highest ranking in its main categories
No Data to Display
Top Competitors & Alternative Apps
Apps with a high probability of being used by the same users, from the same store.
Breast Cancer Club
Gazal Kamal
Breast Cancer Manager
At Point of Care, LLC
My Risk Breast Cancer
Matthew Culbert
Breast Cancer [BC]
At Point of Care, LLC
Breast Cancer Survivorship VS.
December 24, 2024